LUXABENDAZOLE
UNII 34S1S00GV3

Substance Identification & Data

This profile provides standardized clinical and technical data for Luxabendazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 34S1S00GV3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 90509-02-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

34S1S00GV3

CAS Registry Number

90509-02-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LUXABENDAZOLE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H12FN3O5S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ZVIDWFUBDDXAJA-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66043

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

72019

Unique identification number in the NCBI database of chemical substances.

INN ID

5628

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cc(S(Oc2cc3c(cc2)nc([nH]3)NC(OC)=O)(=O)=O)ccc1F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Luxabendazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.